4-(苄氧基)-2-甲基苯胺 | 4792-60-3

• 物质功能分类: 有机原料 - 氨基化合物 - 环烷胺、芳香单胺、芳香多胺及其衍生物和盐
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 4-(苄氧基)-2-甲基苯胺
• 英文名称: 4-(benzyloxy)-2-methylaniline
• 英文别名: 2-methyl-4-benzyloxyaniline；2-methyl-4-phenylmethoxyaniline
• CAS: 4792-60-3
• 化学式: C₁₄H₁₅NO
• 分子量: 213.279
• InChiKey: YMZVPMQBIGSBOW-UHFFFAOYSA-N

物化性质

• 熔点：
  95.5 °C
• 沸点：
  120-122 °C(Press: 0.01 Torr)
• 密度：
  1.106±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2922199090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(Benzyloxy)-2-methylaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(Benzyloxy)-2-methylaniline
CAS number: 4792-60-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H15NO
Molecular weight: 213.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(苄氧基)-2-甲基苯胺 在 palladium on activated charcoal 氢氧化钾 、 potassium dihydrogenphosphate 、 CuO/Cr₂O₃ 、 potassium nitrososulfonate 、 氢气 作用下， 以 喹啉 、 甲醇 、 水 、 乙腈 为溶剂， 200.0 ℃ 、405.3 kPa 条件下， 反应 16.25h， 生成 3,7-二甲基-1H-吲哚-4,5-二酮
  参考文献：
  名称：

  Synthesis, Physicochemical Properties, and Amine-Oxidation Reaction of Indolequinone Derivatives as Model Compounds of Novel Organic Cofactor TTQ of Amine Dehydrogenases

  摘要：

  3,4-Disubstituted 6,7-indolequinones [1,3-dimethyl-4-(3'-methylindol-2'-yl)indole-6,7-dione (2), 3-methyl-4-phenylindole-6,7-dione (3), and 3,4-dimethyl-6,7-dione (4)] and a 3,7-disubstituted 4,5-indolequinone [3,7-dimethylindole-4,5-dione (5)] have been synthesized as models for the novel organic cofactor TTQ of bacterial amine dehydrogenases. The substituent and structural effects on the physicochemical properties of the quinones have been investigated in detail by comparing the spectroscopic data (UV-vis, IR, H-1- and C-13-NMR), pK(a) values of the pyrrole proton, and the two-electron redox potentials with those of model compound 1 [3-methyl-4-(3'-methylindol-2'-yl)indole-6,7-dione] previously reported (ref 5). Reactivity of each quinone in the transamination process [iminoquinone formation (k(1)), rearrangement to product-imine (k(2)), and aminophenol formation (k(3))] has been investigated kinetically, revealing that the substituent and structural effects on the amine-oxidation reaction are not so significant. In the aerobic catalytic oxidation of benzylamine, however, the aromatic substituents on the quinone ring play an important role to protect the quinone from the deactivation process of a Michael-type addition by the amine, making it act as an efficient turnover catalyst.

  DOI：

  10.1021/jo970716l
• 作为产物：
  描述：

  4-硝基间甲苯酚 在 铁粉 、 potassium carbonate 作用下， 以 四氢呋喃 、 乙醇 、 水 为溶剂， 反应 3.0h， 生成 4-(苄氧基)-2-甲基苯胺
  参考文献：
  名称：

  Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine phosphorylase11Abbreviations: AEAC, 6-(2-aminoethyl)amino-5-chlorouracil; CIMU, 5-chloro-6-(1-imidazolyl-methyl) uracil; FGF, fibroblast growth factor; HUVEC, human umbilical vein endothelial cell(s); PD-ECGF, platelet-derived endothelial cell growth factor; PNP, purine nucleoside phosphorylase; TGF, transforming growth factor; TNF-α, tumor necrosis factor-α; TP, thymidine phosphorylase; UP, uridine phosphorylase; and VEGF, vascular endothelial growth factor.

  摘要：

  Thymidine phosphorylase (TP) catalyzes the reversible phosphorolysis of thymidine and other pyrimidine 2'-deoxyribonucleosides. In addition, TP has been shown to possess angiogenic activity in a number of in vitro and in vivo assays, and its angiogenic activity has been linked to its catalytic activity. A series of 5- and 6-substituted uracil derivatives were synthesized and evaluated for their abilities to inhibit TP activity. Among the most active compounds was a 6-amino-substituted uracil analog, 6-(2-aminoethyl)amino-5-chlorouracil (AEAC), which was a competitive inhibitor with a K-i of 165 nM. The inhibitory activity of AEAC was selective for TP, as it did not inhibit purine nucleoside phosphorylase or uridine phosphorylase at concentrations up to 1 mM. Human recombinant TP induced human umbilical vein endothelial cell (HUVEC) migration in a modified Boyden chamber assay in vitro, and this action could be abrogated by the TP inhibitors. The actions of the inhibitors were specific for TP, as they had no effect on the chemotactic actions of vascular endothelial growth factor (VEGF). HUVEC migration was also induced when TP-transfected human colon and breast carcinoma cells were co-cultured in the Boyden chamber assay in place of the purified angiogenic factors, and a TP inhibitor blocked the tumor cell-mediated migration almost completely. These studies suggest that inhibitors of TP may be useful in pathological conditions that are dependent upon TP-driven angiogenesis. (C) 2001 Elsevier Science Inc. All rights reserved.

  DOI：

  10.1016/s0006-2952(01)00783-3

文献信息

• Microwave‐assisted reduction of aromatic nitro compounds with novel oxo‐rhenium complexes
  作者：Gabriele Grieco、Olivier Blacque

  DOI：10.1002/aoc.6452

  日期：2022.1

  The reduction of several aromatic nitro compounds to amines by means of the two novel catalytic systems ([IMes]2ReOBr3)/PhSiH3 and ([Py]3ReNOBr2)/PhSiH3 under microwave irradiation is here reported. These two systems were able to perform the reduction of nitro groups with higher TON and TOF when compared with previously reported systems based on oxo-rhenium core under standard heating, although they

  本文报道了在微波辐照下通过两种新型催化体系([IMes] 2 ReOBr 3 )/PhSiH 3和([Py] 3 ReNOBr 2 )/PhSiH 3将几种芳族硝基化合物还原为胺。与先前报道的基于氧铼核的系统在标准加热下相比，这两个系统能够以更高的 TON 和 TOF 还原硝基，尽管与已知系统相比，它们的反应范围较窄。
• Novel organophosphorus derivatives of indazoles and use thereof as medicinal products
  申请人：Cherrier Marie-Pierre

  公开号：US20050137171A1

  公开（公告）日：2005-06-23

  The present invention relates in particular to novel chemical compounds, particularly to novel organophosphorus derivatives of indazoles, to the compositions containing them, and to the use thereof as medicinal products for treating cancers.

  本发明特别涉及新型化合物，特别是吲唑的新型有机磷衍生物，包含它们的组合物，以及将其用作治疗癌症的药物产品。
• [EN] COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR<br/>[FR] COMPOSÉS, COMPOSITIONS ET MÉTHODES PERMETTANT DE MODULER LE CFTR
  申请人：PROTEOSTASIS THERAPEUTICS INC

  公开号：WO2017062581A1

  公开（公告）日：2017-04-13

  The present disclosure is directed to disclosed compounds that modulate, e.g., address underlying defects in cellular processing of CFTR activity.

  本公开涉及揭示的化合物，可以调节，例如，解决CFTR活性细胞处理中的潜在缺陷。
• Pyrrolo [3,2-c] quinoline derivatives containing haloalkoxy group and
  申请人：Korea Research Institute of Chemical Technology

  公开号：US06011044A1

  公开（公告）日：2000-01-04

  The present invention relates to a novel pyrrolo[3,2-c]quinoline derivatives containing haloalkoxy group, represented by Formula I, their pharmaceutically acceptable salts; process for preparation thereof; and pharmaceutical composition thereof for treating gastric ulcer. ##STR1## in which R.sub.1 is haloalkoxy group of C.sub.1 -C.sub.6 including trifluoromethoxy, difluoromethoxy and trifluoroethoxy group. R.sub.2 and R.sub.3, which are the same or different, are each hydrogen, halogen, hydroxy, benzyloxy, alkyl group of C.sub.1 -C.sub.6, alkoxy group of C.sub.1 -C.sub.6. A is --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--, and R.sub.4 is hydrogen, halogen, amino, alkylamino group of C.sub.1 -C.sub.6, and NH(CH.sub.2).sub.n OH in which n is 1-6. Pyrrolo[3,2-c]quinoline derivatives having haloalkoxy group, and their pharmaceutically acceptable salts, which reversibly inhibit gastric acid secretion of mammal, are usefully utilized for gastric ulcer therapeutics.

  本发明涉及一种含有卤代烷氧基团的新型吡咯并[3,2-c]喹啉衍生物，其由式I表示，其药学上可接受的盐；其制备方法；以及用于治疗胃溃疡的药物组合物。其中，R.sub.1是包括三氟甲氧基、二氟甲氧基和三氟乙氧基等C.sub.1-C.sub.6的卤代烷氧基团。R.sub.2和R.sub.3，相同或不同，分别是氢、卤素、羟基、苄氧基、C.sub.1-C.sub.6的烷基、C.sub.1-C.sub.6的烷氧基。A是--CH.sub.2--CH.sub.2--或--CH.dbd.CH--，而R.sub.4是氢、卤素、氨基、C.sub.1-C.sub.6的烷基氨基团，以及NH(CH.sub.2).sub.n OH，其中n为1-6。具有卤代烷氧基团的吡咯并[3,2-c]喹啉衍生物及其药学上可接受的盐，可逆地抑制哺乳动物的胃酸分泌，可用于胃溃疡治疗。
• Nitrogen-containing aromatic derivatives
  申请人：——

  公开号：US20040053908A1

  公开（公告）日：2004-03-18

  Compounds represented by the following general formula: 1 [wherein A g is an optionally substituted 5- to 14-membered heterocyclic group, etc.; X g is —O—, —S—, etc.; Y g is an optionally substituted C 6 - 14 aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and T g1 is a group represented by the following general formula: 2 (wherein E g is a single bond or —N(R g2 )—, R g1 and R g2 each independently represent a hydrogen atom, an optionally substituted C 1-6 alkyl group, etc. and Z g represents a C 1-8 alkyl group, a C 3-8 alicyclic hydrocarbon group, a C 6-14 aryl group, etc.)], salts thereof or hydrates of the foregoing.

  由以下一般式表示的化合物： 1 [其中 A g 是可选择地取代的5-至14-成员杂环基团，等等；X g 是—O—，—S—，等等；Y g 是可选择地取代的C 6 - 14 芳基团，可选择地取代的5-至14-成员杂环基团，等等；以及 T g1 是由以下一般式表示的基团： 2 [其中 E g 是单键或—N(R g2 )—，R g1 和R g2 各自独立地表示氢原子，可选择地取代的C 1-6 烷基基团，等等，Z g 表示C 1-8 烷基基团，C 3-8 脂环烃基团，C 6-14 芳基团，等等]， 其盐或上述化合物的水合物。